JSR Corp (JSR) is primarily engaged in the manufacturing and selling of various products across different sectors. The company’s business portfolio is diverse and spans across multiple sectors. JSR's products are used in the production of semiconductor chips, LCD and OLED displays, 3D printing, drug therapies, and in the manufacturing of automobile parts, household appliances, and building materials. The company's activities are divided into three reportable segments: Digital Solutions Business, Life Sciences Business, and Plastics Business. In FY2025, the company’s capital expenditure stood at JPY27,024 million, which decreased 6.5% YoY.

JSR is engaged in a variety of R&D initiatives, focusing on the development and delivery of advanced materials for display technologies, semiconductor technology, optical components, and life sciences. The company is involved in creating materials that enhance display performance, support semiconductor scaling, and contribute to the advancement of optical and medical technologies. JSR also emphasizes the integration of next-generation computer technology and data science to accelerate R&D operations and foster innovation. The R&D units of JSR include the Display Solution Development Center, Fine Electronic Materials Development Center, Optical Solution Lab, RD Technology and Digital Transformation Center, JSR-Keio University Medical and Chemical Innovation Center (JKiC), and JSR Bioscience and Informatics R&D Center (JSR BiRD). Each unit is responsible for specific areas: the Display Solution Development Center focuses on materials for display technologies; the Fine Electronic Materials Development Center works on semiconductor materials; the Optical Solution Lab develops materials for optical components; the RD Technology and Digital Transformation Center accelerates R&D through advanced technology; JKiC collaborates on medical and chemical innovations; and JSR BiRD focuses on life sciences and informatics. The company holds a significant number of patents, with 1,794 in Japan and 2,244 overseas as of FY2025. In FY2025, the company incurred R&D expense of JPY26,087 million, which was 6.4% of the company's total revenue and grew by 0.6% YoY.